インターヴェンショナル腫瘍学の世界市場2017-2021...市場調査レポートについてご紹介

【英文タイトル】Global Interventional Oncology Market 2017-2021

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
PART 01: Executive summary

PART 02: Scope of the report
• Market overview
• Top-vendor offerings

PART 03: Market research methodology
• Research methodology
• Economic indicators

PART 04: Introduction
• Key market highlights

PART 05: Market landscape
• Market overview
• Five force analysis

PART 06: Market segmentation by procedure
• Ablation
• Global interventional oncology ablation market
• Embolization
• Global interventional oncology embolization market

PART 07: Geographical segmentation
• Interventional oncology market in Americas
• Interventional oncology market in EMEA
• Interventional oncology market in APAC

PART 08: Market drivers
• Growing cancer population
• Growing R&D activities
• Advances in technology
• Growing demand for MI procedures

PART 09: Impact of drivers

PART 10: Market challenges
• Risks associated with interventional oncology procedures
• High cost of interventional oncology procedures
• Presence of alternatives
• Limited skilled practitioners

PART 11: Impact of drivers and challenges

PART 12: Market trends
• Growing integration of image-guided solutions with interventional oncology procedures
• Increasing inorganic growth strategies by vendors
• Growing focus toward the adoption of MWA
• Growing adoption of SIRT and HIFU
• Competitive scenario

PART 13: Vendor landscape
• Key news
• Mergers and acquisitions

PART 14: Key vendor analysis
• Boston Scientific
• BTG
• Medtronic
• Merit Medical
• TERUMO CORPORATION
• Other prominent vendors

PART 15: Appendix
• List of abbreviations

[List of Exhibits]

Exhibit 01: Product offerings
Exhibit 02: Key highlights of interventional oncology market
Exhibit 03: Snapshot of global interventional oncology market
Exhibit 04: Global interventional oncology market 2016-2021 ($ millions)
Exhibit 05: Interventional oncology market: Opportunity assessment
Exhibit 06: Five forces analysis
Exhibit 07: Global interventional oncology market segmentation by procedure
Exhibit 08: Global interventional oncology market segmentation by procedure 2016 and 2021
Exhibit 09: Global interventional oncology market segmentation by procedure 2016
Exhibit 10: Global interventional oncology market segmentation by procedure 2016: Lifecycle analysis
Exhibit 11: Global interventional oncology ablation market: Snapshot
Exhibit 12: Global interventional oncology ablation market 2016-2021 ($ millions)
Exhibit 13: Global interventional oncology embolization market: Snapshot
Exhibit 14: Global interventional oncology embolization market 2016-2021 ($ millions)
Exhibit 15: Global interventional oncology market segmentation by procedure 2016-2021 ($ millions)
Exhibit 16: Global interventional oncology market segmentation by procedure type 2016-2021 (%)
Exhibit 17: Global interventional oncology market segmentation by geography 2016 and 2021
Exhibit 18: Global interventional oncology market: Geographical presence
Exhibit 19: Global interventional oncology market segmentation by geography 2016
Exhibit 20: Global interventional oncology market segmentation by geography 2016: Lifecycle analysis
Exhibit 21: Interventional oncology market in Americas 2016-2021 ($ millions)
Exhibit 22: Market overview: Americas
Exhibit 23: Interventional oncology market in EMEA 2016-2021 ($ millions)
Exhibit 24: Market overview: EMEA
Exhibit 25: Interventional oncology market in APAC 2016-2021 ($ millions)
Exhibit 26: Market overview: APAC
Exhibit 27: Global interventional oncology market segmentation by geography 2016-2021 ($ millions)
Exhibit 28: Global interventional oncology market segmentation by geography 2016-2021
Exhibit 29: Impact of drivers
Exhibit 30: Complications associated with interventional oncology procedures
Exhibit 31: Impact of drivers and challenges
Exhibit 32: Major M&A in global interventional oncology market
Exhibit 33: Comparison of MWA over RFA methods
Exhibit 34: Competitive structure analysis of global interventional oncology market 2016
Exhibit 35: Market share analysis of vendors in interventional oncology market 2016
Exhibit 36: Competitive landscape analysis of global interventional oncology market 2016
Exhibit 37: Strategic success factors of companies in global interventional oncology market
Exhibit 38: Boston Scientific: Key highlights
Exhibit 39: Boston Scientific: Strength assessment
Exhibit 40: Boston Scientific: Strategy assessment
Exhibit 41: Boston Scientific: Opportunity assessment
Exhibit 42: BTG: Key highlights
Exhibit 43: BTG: Strength assessment
Exhibit 44: BTG: Strategy assessment
Exhibit 45: BTG: Opportunity assessment
Exhibit 46: Medtronic: Key highlights
Exhibit 47: Medtronic: Strength assessment
Exhibit 48: Medtronic: Strategy assessment
Exhibit 49: Medtronic: Opportunity assessment
Exhibit 50: Merit Medical: Key highlights
Exhibit 51: Merit Medical: Strength assessment
Exhibit 52: Merit Medical: Strategy assessment
Exhibit 53: Merit Medical: Opportunity assessment
Exhibit 54: TERUMO CORPORATION: Key highlights
Exhibit 55: TERUMO CORPORATION: Strength assessment
Exhibit 56: TERUMO CORPORATION: Strategy assessment
Exhibit 57: TERUMO CORPORATION: Opportunity assessment


【レポート販売概要】

■ タイトル:インターヴェンショナル腫瘍学の世界市場2017-2021
■ 英文:Global Interventional Oncology Market 2017-2021
■ 発行日:2017年3月13日
■ 調査会社:Technavio
■ 商品コード:IRTNTR12231
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。